Classic ischemic but not pharmacologic preconditioning is abrogated following genetic ablation of the TNFalpha gene - PubMed (original) (raw)
Comparative Study
Classic ischemic but not pharmacologic preconditioning is abrogated following genetic ablation of the TNFalpha gene
Robert M Smith et al. Cardiovasc Res. 2002.
Abstract
Objective: Tumor necrosis factor alpha (TNFalpha) is known to mimic ischemic preconditioning (IP). However, it is not known whether TNFalpha-preconditioning is mediated by 'established' preconditioning signaling or via novel signaling cascades. Moreover, whether TNFalpha is required to induce the ischemic preconditioning phenotype has not been determined.
Methods: To evaluate the role of TNFalpha, we determined the infarct-sparing effect of IP comparing TNFalpha null (TNFalpha-/-) and wild-type mice. The IP protocol included 4x5 min ischemia/reperfusion (I/R) prior to the index 35 min of global ischemia followed by 45 min of reperfusion in isolated perfused murine hearts. Infarct size was measured as a percentage of cardiac volume. To evoke particular signaling pathways numerous pharmacologic studies were performed.
Results: Following IP, infarct size was significantly reduced by 43% in wild-type mice. In contrast, infarct size was not attenuated by IP in the TNFalpha-/- group versus I/R controls (Infarct size-36+/-3%). Interestingly, pharmacologic preconditioning with adenosine (100 microM) and diazoxide (30 microM) mimicked IP in both the wild-type (infarct size-11+/-4% and 18+/-2%) and in TNFalpha-/- mice (infarct size-15+/-4% and 23+/-3%) versus respective I/R controls. Recombinant TNFalpha (0.5 ng/ml) administered for 7 min followed by a 10-min washout mimicked IP in wild-type mice but not in the TNFalpha deficient mouse hearts. The cardioprotective effects of IP, adenosine and TNFalpha were abolished by the co-administration of the putative mitochondrial K(ATP) blocker 5-hydroxydecanoate.
Conclusions: We demonstrate that cardiac TNFalpha production is required for ischemic preconditioning-induced cardioprotection but not necessary in pharmacologic preconditioning with adenosine or diazoxide in TNFalpha-/- mice. Moreover, TNFalpha administration is sufficient to activate preconditioning in wild-type mice. Finally, as 5-hydroxydecanoate abrogates ischemic, adenosine and TNFalpha induced preconditioning, this suggests that diverse signaling pathways converge at the level of mitochondrial K(ATP) channel activation to mediate this cardioprotection.
Similar articles
- Effects of mitochondrial K(ATP) modulators on cardioprotection induced by chronic high altitude hypoxia in rats.
Neckár J, Szárszoi O, Koten L, Papousek F, Ost'ádal B, Grover GJ, Kolár F. Neckár J, et al. Cardiovasc Res. 2002 Aug 15;55(3):567-75. doi: 10.1016/s0008-6363(02)00456-x. Cardiovasc Res. 2002. PMID: 12160954 - Adenosine-mediated early preconditioning in mouse: protective signaling and concentration dependent effects.
Peart J, Headrick JP. Peart J, et al. Cardiovasc Res. 2003 Jun 1;58(3):589-601. doi: 10.1016/s0008-6363(03)00259-1. Cardiovasc Res. 2003. PMID: 12798432 - Critical timing of mitochondrial K(ATP) channel opening for enhancement of myocardial tolerance against infarction.
Tsuchida A, Miura T, Miki T, Kuno A, Tanno M, Nozawa Y, Genda S, Matsumoto T, Shimamoto K. Tsuchida A, et al. Basic Res Cardiol. 2001 Sep;96(5):446-53. doi: 10.1007/s003950170026. Basic Res Cardiol. 2001. PMID: 11605991 - Preconditioning of the myocardium by volatile anesthetics.
Kwok WM, Aizawa K. Kwok WM, et al. Curr Med Chem Cardiovasc Hematol Agents. 2004 Jul;2(3):249-55. doi: 10.2174/1568016043356318. Curr Med Chem Cardiovasc Hematol Agents. 2004. PMID: 15320790 Review. - The protective and anti-protective effects of ethanol in a myocardial infarct model.
Krenz M, Cohen MV, Downey JM. Krenz M, et al. Ann N Y Acad Sci. 2002 May;957:103-14. doi: 10.1111/j.1749-6632.2002.tb02909.x. Ann N Y Acad Sci. 2002. PMID: 12074965 Review.
Cited by
- Endless Journey of Adenosine Signaling in Cardioprotective Mechanism of Conditioning Techniques: Clinical Evidence.
Kumar K, Singh N, Yadav HN, Maslov L, Jaggi AS. Kumar K, et al. Curr Cardiol Rev. 2023;19(6):56-71. doi: 10.2174/1573403X19666230612112259. Curr Cardiol Rev. 2023. PMID: 37309766 Free PMC article. Review. - Regulation of STAT3 and its role in cardioprotection by conditioning: focus on non-genomic roles targeting mitochondrial function.
Comità S, Femmino S, Thairi C, Alloatti G, Boengler K, Pagliaro P, Penna C. Comità S, et al. Basic Res Cardiol. 2021 Oct 12;116(1):56. doi: 10.1007/s00395-021-00898-0. Basic Res Cardiol. 2021. PMID: 34642818 Free PMC article. Review. - The Role of O-GlcNAcylation for Protection against Ischemia-Reperfusion Injury.
Jensen RV, Andreadou I, Hausenloy DJ, Bøtker HE. Jensen RV, et al. Int J Mol Sci. 2019 Jan 18;20(2):404. doi: 10.3390/ijms20020404. Int J Mol Sci. 2019. PMID: 30669312 Free PMC article. Review. - The Dual Role of Inducible Nitric Oxide Synthase in Myocardial Ischemia/Reperfusion Injury: Friend or Foe?
Yu X, Ge L, Niu L, Lian X, Ma H, Pang L. Yu X, et al. Oxid Med Cell Longev. 2018 Oct 28;2018:8364848. doi: 10.1155/2018/8364848. eCollection 2018. Oxid Med Cell Longev. 2018. PMID: 30510628 Free PMC article. Review. - Remote ischemic conditioning: a promising therapeutic intervention for multi-organ protection.
Zhou D, Ding J, Ya J, Pan L, Wang Y, Ji X, Meng R. Zhou D, et al. Aging (Albany NY). 2018 Aug 16;10(8):1825-1855. doi: 10.18632/aging.101527. Aging (Albany NY). 2018. PMID: 30115811 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases